Prognosis of Stage Iii Non-Small-Cell Lung Cancer Patients Presenting with Isolated Brain Failure After Definitive Concurrent Chemoradiation Therapy

dc.contributor.authorTopkan, E.
dc.contributor.authorGuler, O. C.
dc.contributor.authorYildirim, B. A.
dc.contributor.orcID0000-0001-6661-4185en_US
dc.contributor.orcID0000-0001-8120-7123en_US
dc.contributor.orcID0000-0001-6908-3412en_US
dc.contributor.researcherIDV-5717-2017en_US
dc.contributor.researcherIDAAG-2213-2021en_US
dc.contributor.researcherIDAAC-5654-2020en_US
dc.date.accessioned2024-02-14T07:50:18Z
dc.date.available2024-02-14T07:50:18Z
dc.date.issued2015
dc.identifier.eissn1569-8041en_US
dc.identifier.issn0923-7534en_US
dc.identifier.issueSupplement 1en_US
dc.identifier.urihttp://hdl.handle.net/11727/11513
dc.identifier.volume26en_US
dc.identifier.wos000354728700036en_US
dc.language.isoengen_US
dc.relation.journalANNALS OF ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titlePrognosis of Stage Iii Non-Small-Cell Lung Cancer Patients Presenting with Isolated Brain Failure After Definitive Concurrent Chemoradiation Therapyen_US
dc.typeConference Objecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: